Antenatal betamethasone treatment has a persisting influence on infant HPA axis regulation

J Perinatol. 2006 Mar;26(3):147-53. doi: 10.1038/sj.jp.7211447.

Abstract

Objective: To examine the consequences of antenatal betamethasone (AB) exposure on postnatal stress regulation.

Study design: Fourteen AB exposed infants born at 28-30 weeks' gestation were assessed in the NICU during postnatal week 1 and at 34 weeks postconception. Nine infants born at 34 weeks gestation without AB treatment were evaluated as a postconceptional age comparison group. Salivary cortisol, heart rate, and behavior were measured at baseline and in response to a heelstick blood draw.

Results: Repeated measures ANOVAs revealed that both groups displayed an increase in heart rate and behavioral distress in response to the stressor. The cortisol response, however, was blunted in AB-treated infants at both assessments.

Conclusion: AB treatment has consequences for hypothalamic-pituitary-adrenal (HPA) axis regulation that persist for at least four to six weeks after birth, indicating that studies of long-term effects are warranted.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Apgar Score
  • Betamethasone / adverse effects*
  • Betamethasone / therapeutic use
  • Case-Control Studies
  • Cohort Studies
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Gestational Age
  • Heart Rate / drug effects
  • Humans
  • Hydrocortisone / metabolism
  • Infant, Newborn
  • Infant, Premature*
  • Intensive Care Units, Neonatal
  • Male
  • Pituitary-Adrenal Function Tests
  • Pituitary-Adrenal System / drug effects*
  • Pituitary-Adrenal System / physiopathology
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Reference Values
  • Stress, Psychological
  • Time Factors

Substances

  • Betamethasone
  • Hydrocortisone